Trial Profile
A Phase 1, Single-Center, Split-Face Study Assessing Local Cutaneous Effects After Application of SB204 2% and SB204 4% in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2018
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Novan Inc
- 29 Sep 2014 New trial record